NOVATO, Calif., Aug. 7, 2012 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), today announced that Ted Daley, President of Raptor, will present an overview of the Company at two investor conferences in August.
The conference presentation schedule is as follows:
| Canaccord Genuity Annual Growth Conference |
| August 14, 2012 at 10:00am ET |
| InterContinental, Boston, MA |
| Wedbush PACGROW LIFE SCIENCES Management Access Conference |
| August 15, 2012 at 1:55pm ET |
| Le Parker Meridien, New York, NY |
A live audio webcast and 14-day archive of the Canaccord and Wedbush presentations will be available at http://ir.raptorpharma.com/events.cfm
About Raptor Pharmaceutical Corp.
Raptor Pharmaceutical Corp. (Nasdaq:RPTP) ("Raptor") seeks to research, produce, and deliver medicines that improve life for patients with severe, rare disorders. Raptor currently has product candidates in clinical development to potentially treat nephropathic cystinosis, Non-alcoholic Steatohepatitis ("NASH"), Huntington's Disease ("HD"), aldehyde dehydrogenase deficiency ("ALDH2"), and thrombotic disorder.
Raptor's preclinical programs are based upon bioengineered novel drug candidates and drug-targeting platforms derived from the human receptor-associated protein and related proteins that are designed to target cancer and infectious diseases.
For additional information, please visit www.raptorpharma.com.
The Raptor Pharmaceutical Corp. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=7180